Found: 86
Select item for more details and to access through your institution.
Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1548, doi. 10.1007/s10637-011-9715-4
- By:
- Publication type:
- Article
Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome‐wide association and whole genome sequencing analyses.
- Published in:
- Cancer Communications, 2024, v. 44, n. 2, p. 287, doi. 10.1002/cac2.12498
- By:
- Publication type:
- Article
Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk.
- Published in:
- International Journal of Cancer, 2005, v. 114, n. 5, p. 730, doi. 10.1002/ijc.20790
- By:
- Publication type:
- Article
Impact of the haplotype CYP3A4*16B harboring the Thr185Ser substitution on paclitaxel metabolism in Japanese patients with cancer<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 2, p. 179, doi. 10.1016/j.clpt.2006.04.012
- By:
- Publication type:
- Article
Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs.
- Published in:
- Carcinogenesis, 2010, v. 31, n. 10, p. 1794, doi. 10.1093/carcin/bgq159
- By:
- Publication type:
- Article
Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypes.
- Published in:
- Carcinogenesis, 2010, v. 31, n. 5, p. 834, doi. 10.1093/carcin/bgq003
- By:
- Publication type:
- Article
Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese.
- Published in:
- Carcinogenesis, 2009, v. 30, n. 1, p. 65, doi. 10.1093/carcin/bgn257
- By:
- Publication type:
- Article
Association of KRAS polymorphisms with risk for lung adenocarcinoma accompanied by atypical adenomatous hyperplasias.
- Published in:
- Carcinogenesis, 2008, v. 29, n. 5, p. 957, doi. 10.1093/carcin/bgn048
- By:
- Publication type:
- Article
Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers.
- Published in:
- Carcinogenesis, 2004, v. 25, n. 12, p. 2451, doi. 10.1093/carcin/bgh258
- By:
- Publication type:
- Article
Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1.
- Published in:
- Carcinogenesis, 2002, v. 23, n. 7, p. 1177, doi. 10.1093/carcin/23.7.1177
- By:
- Publication type:
- Article
Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.
- Published in:
- Nature Communications, 2016, v. 7, n. 8, p. 12451, doi. 10.1038/ncomms12451
- By:
- Publication type:
- Article
A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population.
- Published in:
- Nature Genetics, 2012, v. 44, n. 8, p. 900, doi. 10.1038/ng.2353
- By:
- Publication type:
- Article
Gender Differences in Treatment Outcomes among Patients with Non-Small Cell Lung Cancer Given a Combination of Carboplatin and Paclitaxel.
- Published in:
- Oncology, 2008, v. 75, n. 3/4, p. 169, doi. 10.1159/000159268
- By:
- Publication type:
- Article
Quality of life with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: quality of life analysis of TORG 0503.
- Published in:
- Quality of Life Research, 2023, v. 32, n. 9, p. 2629, doi. 10.1007/s11136-023-03424-y
- By:
- Publication type:
- Article
Prognostic significance of ground-glass areas within tumours in non-small-cell lung cancer.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2024, v. 65, n. 4, p. 1, doi. 10.1093/ejcts/ezae158
- By:
- Publication type:
- Article
Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: a Cancer-VTE Registry subanalysis.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 407, doi. 10.1007/s10147-024-02475-6
- By:
- Publication type:
- Article
Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patients.
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 70, n. 2, p. 222, doi. 10.1111/j.1365-2125.2010.03695.x
- By:
- Publication type:
- Article
Prognostic factors for malignant pericardial effusion treated by pericardial drainage in solid-malignancy patients.
- Published in:
- Medical Oncology, 2007, v. 24, n. 4, p. 425, doi. 10.1007/s12032-007-0033-9
- By:
- Publication type:
- Article
A Phase II Study of Cisplatin and Irinotecan as Induction Chemotherapy Followed by Accelerated Hyperfractionated Thoracic Radiotherapy with Daily Low-dose Carboplatin in Unresectable Stage III Non-small Cell Lung Cancer: JCOG 9510.
- Published in:
- Japanese Journal of Clinical Oncology, 2009, v. 39, n. 12, p. 784, doi. 10.1093/jjco/hyp102
- By:
- Publication type:
- Article
Gender Difference in Treatment Outcomes in Patients with Stage III Non-small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy.
- Published in:
- Japanese Journal of Clinical Oncology, 2009, v. 39, n. 11, p. 707, doi. 10.1093/jjco/hyp095
- By:
- Publication type:
- Article
Efficacy and Safety of Pemetrexed in Combination with Cisplatin for Malignant Pleural Mesothelioma: A Phase I/II Study in Japanese Patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2008, v. 38, n. 5, p. 339, doi. 10.1093/jjco/hyn024
- By:
- Publication type:
- Article
Effect of Platinum Combined with Irinotecan or Paclitaxel against Large Cell Neuroendocrine Carcinoma of the Lung.
- Published in:
- Japanese Journal of Clinical Oncology, 2007, v. 37, n. 7, p. 482, doi. 10.1093/jjco/hym053
- By:
- Publication type:
- Article
Serum Total Bilirubin as a Predictive Factor for Severe Neutropenia in Lung Cancer Patients Treated with Cisplatin and Irinotecan.
- Published in:
- Japanese Journal of Clinical Oncology, 2007, v. 37, n. 5, p. 358, doi. 10.1093/jjco/hym033
- By:
- Publication type:
- Article
Concurrent Chemoradiotherapy for Limited-disease Small Cell Lung Cancer in Elderly Patients Aged 75 Years or Older.
- Published in:
- Japanese Journal of Clinical Oncology, 2007, v. 37, n. 3, p. 181, doi. 10.1093/jjco/hym005
- By:
- Publication type:
- Article
Phase I Study of Cisplatin Analogue Nedaplatin, Paclitaxel, and Thoracic Radiotherapy for Unresectable Stage III Non-Small Cell Lung Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2007, v. 37, n. 3, p. 175, doi. 10.1093/jjco/hym008
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Weekly Epoetin Beta in Lung Cancer Patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2006, v. 36, n. 8, p. 477, doi. 10.1093/jjco/hyl074
- By:
- Publication type:
- Article
Study of Paclitaxel and Dose Escalation of Cisplatin in Patients with Advanced Non-small Cell Lung Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2003, v. 33, n. 12, p. 626, doi. 10.1093/jjco/hyg116
- By:
- Publication type:
- Article
Phase I/II Study of 3-Week Cycle Cisplatin–Gemcitabine in Advanced Non-small Cell Lung Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2002, v. 32, n. 2, p. 43, doi. 10.1093/jjco/hyf013
- By:
- Publication type:
- Article
A Phase I/II Study of Cisplatin and Vinorelbine Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2001, v. 31, n. 12, p. 596, doi. 10.1093/jjco/hye129
- By:
- Publication type:
- Article
A Dose Escalation Study of Paclitaxel and Carboplatinin Untreated Japanese Patients with Advanced Non-small Cell LungCancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2001, v. 31, n. 10, p. 482, doi. 10.1093/jjco/hye111
- By:
- Publication type:
- Article
Phase I and Pharmacological Study of Paclitaxel Given Over 3 h with Cisplatin for Advanced Non-small Cell Lung Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2001, v. 31, n. 3, p. 93, doi. 10.1093/jjco/hye022
- By:
- Publication type:
- Article
Phase I Studies of Cisplatin and Docetaxel Administered by Three Consecutive Weekly Infusions for Advanced Non-small Cell Lung Cancer in Elderly and Non-elderly Patients.
- Published in:
- Japanese Journal of Clinical Oncology, 2001, v. 31, n. 3, p. 100, doi. 10.1093/jjco/hye019
- By:
- Publication type:
- Article
Phase I Study of a Weekly Infusion of Irinotecan Hydrochloride (CPT-11) and a 14-day Continuous Infusion of Etoposide in Patients with Lung Cancer: JCOG Trial 9408.
- Published in:
- Japanese Journal of Clinical Oncology, 2000, v. 30, n. 11, doi. 10.1093/jjco/hyd129
- By:
- Publication type:
- Article
Platinum-based Chemotherapy with or without Thoracic Radiation Therapy in Patients with Unresectable Thymic Carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2000, v. 30, n. 9, doi. 10.1093/jjco/hyd108
- By:
- Publication type:
- Article
Cancer Chemotherapy in the Elderly.
- Published in:
- Japanese Journal of Clinical Oncology, 1998, v. 28, n. 8, p. 463, doi. 10.1093/jjco/28.8.463
- By:
- Publication type:
- Article
Factors that Influence the Eligibility of Cases for Inclusion in Clinical Trials.
- Published in:
- Japanese Journal of Clinical Oncology, 1998, v. 28, n. 3, p. 214
- By:
- Publication type:
- Article
High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 10, p. 2006, doi. 10.1111/1759-7714.13187
- By:
- Publication type:
- Article
Multi-institutional study of osimertinib dose-optimization in non-small cell lung cancer patients with EGFR activating mutation aged 70 years or older ('MONEY' trial).
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 6, p. 730, doi. 10.1093/jjco/hyae032
- By:
- Publication type:
- Article
Message from the Editor-in-Chief.
- Published in:
- Japanese Journal of Clinical Oncology, 2024, v. 54, n. 1, p. 1, doi. 10.1093/jjco/hyad169
- By:
- Publication type:
- Article
Observational study to predict the efficacy and optimal duration of nivolumab treatment in patients with previously treated advanced or recurrent non-small cell lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 2, p. 153, doi. 10.1093/jjco/hyac159
- By:
- Publication type:
- Article
Message from the Editor-in-Chief.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 1, p. 1, doi. 10.1093/jjco/hyac196
- By:
- Publication type:
- Article
Association between tumor response to systemic therapy and patient-reported disease symptoms.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 12, p. 1423, doi. 10.1093/jjco/hyac142
- By:
- Publication type:
- Article
Final report on plasma ctDNA T790M monitoring during EGFR-TKI treatment in patients with EGFR mutant non-small cell lung cancer (JP-CLEAR trial).
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 7, p. 783, doi. 10.1093/jjco/hyac032
- By:
- Publication type:
- Article
Publishing inconvenient data.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 5, p. 403, doi. 10.1093/jjco/hyac052
- By:
- Publication type:
- Article
Message from the Editor-in-Chief.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 1, p. 1, doi. 10.1093/jjco/hyab190
- By:
- Publication type:
- Article
Medical costs of Japanese lung cancer patients during end-of-life care.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 5, p. 769, doi. 10.1093/jjco/hyaa259
- By:
- Publication type:
- Article
Medical costs of lung cancer care in Japan during the first one or two years after initial diagnosis.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 5, p. 778, doi. 10.1093/jjco/hyaa258
- By:
- Publication type:
- Article
Message from the Editor-in-Chief.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 1, doi. 10.1093/jjco/hyaa205
- By:
- Publication type:
- Article
Corrigendum to: Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 11, p. 1346, doi. 10.1093/jjco/hyaa160
- By:
- Publication type:
- Article